Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.2 USD | -3.12% | +5.80% | -8.69% |
May. 07 | ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M | MT |
Financials (USD)
Sales 2024 * | 30.52M | Sales 2025 * | 42.22M | Capitalization | 170M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -16M | EV / Sales 2024 * | 5.57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.03 x |
P/E ratio 2024 * |
-9.39
x | P/E ratio 2025 * |
-10
x | Employees | 107 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.5% |
Latest transcript on ClearPoint Neuro, Inc.
1 day | -3.13% | ||
1 week | +5.80% | ||
Current month | +14.18% | ||
1 month | +12.12% | ||
3 months | -15.30% | ||
6 months | +20.16% | ||
Current year | -8.69% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 17-11-06 |
Director of Finance/CFO | 39 | 20-09-28 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 22-10-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 19-08-31 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 21-07-14 |
R. Fletcher
CHM | Chairman | 78 | 17-05-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 6.2 | -3.13% | 78,994 |
24-05-16 | 6.4 | 0.00% | 142,292 |
24-05-15 | 6.4 | +6.49% | 190,975 |
24-05-14 | 6.01 | +2.74% | 125,706 |
24-05-13 | 5.85 | -0.17% | 80,636 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.69% | 175M | |
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |
- Stock Market
- Equities
- CLPT Stock